1983年出生，中共黨員;主任醫(yī)師、副教授

2000至 2007年 北京大學(xué)，臨床醫(yī)學(xué) 碩士;

2007至 2010年 北京大學(xué)腫瘤醫(yī)院，腫瘤外科學(xué) 博士;

2010年 -今 北京大學(xué)腫瘤醫(yī)院胃腸腫瘤中心三病區(qū)，歷任主治醫(yī)師、副主任醫(yī)師、副教授、主任醫(yī)師、知名專家;

期間：2013至2014年，美國紐約斯隆凱特琳癌癥中心(MSKCC)擔(dān)任臨床研究員，進(jìn)行直腸癌等待觀察療法和直腸間質(zhì)瘤的研究工作;

---專業(yè)技能：結(jié)直腸癌微創(chuàng)手術(shù);疑難胃腸道腫瘤，如腹盆腔轉(zhuǎn)移減瘤手術(shù)、惡性胃腸梗阻;直腸癌等待觀察療法;

---教學(xué)：主持北京大學(xué)醫(yī)學(xué)部研究生課程一項(xiàng)：《腫瘤相關(guān)并發(fā)癥的處理和預(yù)防》;參與北京大學(xué)醫(yī)學(xué)部本科生課程一項(xiàng)：《常見惡性實(shí)體腫瘤治療概論》;

---論文：SCI 論著18篇，IF：59.644; 參與撰寫英文外科教科書1部;核心期刊文章若干篇; 美國ASCRS年會(huì)(結(jié)直腸外科醫(yī)師協(xié)會(huì))大會(huì)發(fā)言3次(2009，2014;)，壁報(bào)若干次;完成省部級(jí)課題3項(xiàng);

---學(xué)術(shù)兼職：北京抗癌協(xié)會(huì)大腸癌專委會(huì)秘書長(zhǎng)，中國醫(yī)師協(xié)會(huì)結(jié)直腸腫瘤專業(yè)委員會(huì)器官功能保護(hù)專委會(huì)(學(xué)組)委員等;

1. Wang L, et al. Risk factors for symptomatic anastomotic leakage after low anterior resection for rectal cancer with 30 Gy/10 f/2 w preoperative radiotherapy. World journal of surgery. 2010;34(5):1080-5. 10.1007/s00268-010-0449-9.

2. Yao YF, Wang L, ,et al. Lymph node distribution and pattern of metastases in the mesorectum following total mesorectal excision using the modified fat clearing technique. Journal of clinical pathology. 2011;64(12):1073-7. 10.1136/jclinpath-2011-200190.

3. 王林，等. 新輔助放化療對(duì)直腸癌降期的影響. 中國普外基礎(chǔ)與臨床雜志. 2011;18(11):1147-50.

4. 王林，等. 結(jié)直腸癌的規(guī)范化病理診斷要點(diǎn). 中華胃腸外科雜志. 2012;15(10):1088-91.

5. 王林，等. IIa期結(jié)腸癌的預(yù)后因素. 世界華人消化雜志. 2012;20(36):3816-21.

6. Wang L, et al. Abdominoperineal excision following preoperative radiotherapy for rectal cancer: Unfavorable prognosis even with negative circumferential resection margin. World journal of gastroenterology : WJG. 2014;20(27):9138-45. 10.3748/wjg.v20.i27.9138.

7. Wang L, et al. Prognostic value of pretreatment level of carcinoembryonic antigen on tumour downstaging and early occurring metastasis in locally advanced rectal cancer following neoadjuvant radiotherapy (30 Gy in 10 fractions). Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2014;16(1):33-9. 10.1111/codi.12354.

8. 王林, 等. 直腸惡性腫瘤的新輔助治療：研究現(xiàn)狀與外科決策. 中華普通外科學(xué)文獻(xiàn)(電子版). 2014(3):176-80. 10.3877/cma.j.issn.1674-0793.2014.03.001.

9. 王林, 等. 腹會(huì)陰聯(lián)合切除術(shù)歷史回顧及現(xiàn)狀. 中國實(shí)用外科雜志. 2014;34(9):812-6.

10. 王林, 等. 淋巴結(jié)比率對(duì)術(shù)前30 Gy/10次分割放療后Ⅲ期直腸癌患者預(yù)后的判斷價(jià)值. 中華胃腸外科雜志. 2014(10):990-6. 10.3760/cma.j.issn.1671-0274.2014.10.010.

11. Wang L, Paty P. Open Abdominoperineal Resection. In: Kim J, Garcia-Aguilar J, editors. Surgery for Cancers of the Gastrointestinal Tract: A Step-by-Step Approach. New York, NY: Springer New York; 2015. p. 263-74.

12. Wang L, et al. Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer. Diseases of the colon and rectum. 2015;58(2):186-92. 10.1097/DCR.0000000000000294.

13. Wang L, et al. Prognostic value of CD45RO(+) tumor-infiltrating lymphocytes for locally advanced rectal cancer following 30 Gy/10f neoadjuvant radiotherapy. International journal of colorectal disease. 2015;30(6):753-60. 10.1007/s00384-015-2226-6.

14. Wang L, et al. Intermediate Neoadjuvant Radiotherapy Combined With Total Mesorectal Excision for Locally Advanced Rectal Cancer: Outcomes After a Median Follow-Up of 5 Years. Clinical colorectal cancer. 2016;15(2):152-7. 10.1016/j.clcc.2015.10.001.

15. Cavnar MJ, Wang L, et al. Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome. Annals of surgical oncology. 2017;24(13):3972-80. 10.1245/s10434-017-6087-9.

16. 武愛文, 王林, 等. 中低位直腸癌新輔助治療后等待觀察或器官保留手術(shù)的單中心35例報(bào)告. 中華胃腸外科雜志. 2017;20(4):417-24.

17. Wu AW, Cai Y, Li YH, Wang L, et al. Pattern and Management of Recurrence of Mid-Low Rectal Cancer After Neoadjuvant Intensity-Modulated Radiotherapy: Single-Center Results of 687 Cases. Clinical colorectal cancer. 2018;17(2):e307-e13. 10.1016/j.clcc.2018.01.006.

18. 王林,武愛文, 等. 中低位直腸癌新輔助治療后臨床完全緩解或近臨床完全緩解的長(zhǎng)期預(yù)后分析. 中華胃腸外科雜志. 2018;21(11):1240-8.

19. Chen N, Wang L, Wu AW, et al. Fat clearance and conventional fixation identified ypN0 rectal cancers following intermediate neoadjuvant radiotherapy have similar long-term outcomes. World J Gastrointest Oncol. 2019;11(10):877-86. 10.4251/wjgo.v11.i10.877.

20. Song M, Geng J, Wang L, et al. Excluding the ischiorectal fossa irradiation during neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy followed by abdominoperineal resection decreases perineal complications in patients with lower rectal cancer. Radiat Oncol. 2019;14(1):138. 10.1186/s13014-019-1338-5.

21. 孫婷婷, 王林,武愛文, 等. 直腸癌新輔助治療后"等待觀察"療法:中國外科醫(yī)生的認(rèn)知和態(tài)度及治療選擇現(xiàn)況調(diào)查. 中華胃腸外科雜志. 2019;22(6).

22. Chen PJ, Wang L, Wu AW, et al. Surgical intervention for malignant bowel obstruction caused by gastrointestinal malignancies. World J Gastrointest Oncol. 2020;12(3):323-31. 10.4251/wjgo.v12.i3.323.

23. Sun RJ, Wang L, et al. Baseline MRI detected lateral lymph node as a prognostic factor: a cohort study in pN0 low-risk rectal cancer. Journal of cancer research and clinical oncology. 2020;146(3):739-48. 10.1007/s00432-019-03100-0.

24. Zhang XY, Wang L, et al. Predicting Rectal Cancer Response to Neoadjuvant Chemoradiotherapy Using Deep Learning of Diffusion Kurtosis MRI. Radiology. 2020:190936. 10.1148/radiol.2020190936.

25. 王林,武愛文, 等. 低風(fēng)險(xiǎn)直腸癌患者全程新輔助治療后主動(dòng)性 等待觀察及器官保留策略：一項(xiàng)前瞻性、 單中心、單臂研究(PKUCH?R01)的初步報(bào)告. 中華胃腸外科雜志. 2020;23(3):258-65.

26. 中國直腸癌新輔助治療后等待觀察數(shù)據(jù)庫研究協(xié)作組, 中國醫(yī)師協(xié)會(huì)外科醫(yī)師分會(huì)中國醫(yī)師協(xié)會(huì)肛腸醫(yī)師分會(huì), 中華醫(yī)學(xué)會(huì)外科學(xué)分會(huì)結(jié)直腸外科學(xué)組, 中國醫(yī)師協(xié)會(huì)結(jié)直腸腫瘤醫(yī)師專業(yè)委員會(huì), 中國抗癌協(xié)會(huì)放射治療專業(yè)委員會(huì). 直腸癌新輔助治療后等待觀察策略專家共識(shí)(2020版). 中華胃腸外科雜志. 2020;23(01):1-9.

27. 中國直腸癌新輔助治療后等待觀察數(shù)據(jù)庫研究協(xié)作組(CWWD), 中國醫(yī)師協(xié)會(huì)外科醫(yī)師分會(huì), 中國衛(wèi)生法學(xué)會(huì), 中國醫(yī)師協(xié)會(huì)肛腸醫(yī)師分會(huì), 中國醫(yī)師協(xié)會(huì)放射腫瘤治療醫(yī)師分會(huì), 北京衛(wèi)生法學(xué)會(huì)醫(yī)事法律專業(yè)委員會(huì), 北京衛(wèi)生法學(xué)會(huì)患者安全專業(yè)委員會(huì). 直腸癌新輔助治療后等待觀察策略患者權(quán)益保護(hù)專家共識(shí). 中華胃腸外科雜志. 2020;23(03):220-4.

28. Li S, Geng J, Wang L, et al. Effect of Simultaneous Integrated Boost Intensity Modulated Radiation Therapy (SIB-IMRT) and Non-Operative Strategy on Outcomes of Distal Rectal Cancer Patients with Clinically Positive Lateral Pelvic Lymph Node. Cancer Manag Res. 2021;13:537-46. 10.2147/CMAR.S286796. PMC7837555.

29. Zhang XY, Li XT, Shi YJ, Lu QY, Cao W, Zhang HM, Wang L, et al. Correlation Between the Distance to Mesorectal Fascia and Prognosis of Ct3 Rectal Cancer: A Multicenter Study Results of China. Diseases of the colon and rectum. 2021. 10.1097/DCR.0000000000002167.